Vertex Pharmaceuticals Stock Forecast & Price Target
Vertex Pharmaceuticals Price Target 2026
The Quantum Forecast sees a price target of $559.12 (+2.8%) for Vertex Pharmaceuticals in about one month (by Dec 10, 2026).
Quantum Forecast price targets by time frame, calculated from the current price of $543.67. Click to see the forecast in the chart.
Vertex Pharmaceuticals Forecast for Today and Tomorrow
In the short term, the Quantum Forecast sees Vertex Pharmaceuticals at $543.08 (−0.11%) today around 9:15 AM ET and at $543.22 (−0.08%) today around 2:15 PM ET. It is based on prices from the current trading day and the past week. Short-term forecast in the chart
Vertex Pharmaceuticals Stock 2026: Price Performance
Vertex Pharmaceuticals stock has gained 19.9% since the start of 2026 and currently trades at $543.67 (as of Nov 11, 2026). Over the same period the Nasdaq 100 is up 12.0%, putting the stock 7.9 percentage points ahead of the index. Over the past 52 weeks the price ranged between $412.06 and $571.68; it is currently 4.9% below its high of Nov 2, 2026.
Vertex Pharmaceuticals Forecast 2027
Over a horizon of roughly 10 months (until about Sep 2027), the Quantum Forecast sees a price target of $593.70 for Vertex Pharmaceuticals – +9.2% from today. The range band runs from $404.92 – $782.48: the further ahead the forecast looks, the greater the uncertainty. See the long-term forecast in the chart
Community Forecast for Vertex Pharmaceuticals
2 user forecasts (all years): 100% long, 0% short.
Make your own forecastAbout Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company headquartered in Boston and founded in 1989. It became known for medicines that target the underlying cause of cystic fibrosis, including Kalydeco and Trikafta (sold as Kaftrio in Europe). Together with CRISPR Therapeutics, Vertex developed Casgevy, the first approved therapy based on CRISPR gene editing, for sickle cell disease and beta thalassemia. In 2025 it added Journavx, a non-opioid pain medicine, in the United States.
Its drugs serve patients with serious, often rare diseases and are distributed through hospitals and specialty pharmacies in North America, Europe and other regions. Cystic fibrosis remains the company's core franchise, while research extends to kidney diseases, type 1 diabetes and pain. Vertex combines in-house research with partnerships and targeted acquisitions of drug candidates. For investors, clinical trial results, regulatory decisions and diversification beyond cystic fibrosis are central topics. Its shares trade on the Nasdaq under the symbol VRTX and are included in the Nasdaq-100 and the S&P 500.
The current price of Vertex Pharmaceuticals stock is $543.67 (−1.22% vs. the previous close). In today's trading the high was $546.67 and the low $542.45.
How the Quantum Forecast works
Research from quantum physics. The models are the result of several years of research at the Max Planck Institute of Quantum Optics and LMU Munich and were transferred to the stock market.
Spectra and correlations. Frequency spectra are calculated from current prices, and the relationships between price swings and volatility are analyzed. This produces the forecast and the risk assessment.
Detecting herd behavior. Models of phase transitions from statistical physics describe when investors collectively fall into panic or euphoria – an early sign of possible crash situations.
Swarm intelligence. User forecasts are checked once their time frame has expired and feed into the model, weighted by their hit rate.
The range band shows the typical fluctuation around the forecast. More on quantum physics & swarm intelligence
Frequently Asked Questions about Vertex Pharmaceuticals Stock
What is the Vertex Pharmaceuticals stock forecast?
The Quantum Forecast expects Vertex Pharmaceuticals to reach $559.12 in about one month (by Dec 10, 2026), a change of +2.8% from the current price of $543.67. Over roughly 10 months (by Sep 2027) the price target is $593.70 (+9.2%).
What is the Vertex Pharmaceuticals stock price target?
Quantum Forecast price targets by time frame: 1 month $559.12 (+2.8%), 2 months $514.78 (−5.3%), 6 months $556.61 (+2.4%), 10 months $593.70 (+9.2%). The range band shows the typical fluctuation around these targets.
Will Vertex Pharmaceuticals stock go up or down?
In the short term the Quantum Forecast points up (+2.8% over one month). No forecast is certain – it is based on historical prices and statistical analysis.
How is the Quantum Forecast computed?
Trends, frequency spectra and correlations are calculated from the price history using methods from quantum physics; user opinions are added as well (swarm intelligence). The range band reflects the volatility of the security and widens with the time horizon.
Can I make my own forecast for Vertex Pharmaceuticals?
Yes – in the Forecast League you pick long or short and a price target for 1 day up to 6 months. Forecasts are scored automatically when they expire; correct calls earn points and a spot on the leaderboard.